期刊文献+

TSGF及癌抗原125对卵巢癌联合诊断价值的探讨

The Diagnostic Value of Serum TSGF and CA_(125) on Ovarian Tumors
暂未订购
导出
摘要 目的 :探讨TSGF(TumorSuppliedGroupofFactors)和癌抗原 1 2 5(CA1 2 5)联合诊断卵巢恶性肿瘤的价值。方法 :同时测定 83例盆腔包块患者血清TSGF和CA1 2 5水平 ,其中术后病理证实为卵巢癌 30例、卵巢良性肿瘤 37例和盆腔子宫内膜异位囊肿 1 6例 ,分析这两个指标的临床价值。结果 :①卵巢癌组TSGF、CA1 2 5水平分别为 ( 79.6 2± 1 3.58)U ml,( 2 51 .2 3± 2 72 .48)U ml,明显高于内膜异位症组 [( 58.47± 1 4.51 )U ml,( 6 9.76± 1 0 9.73)U mlP <0 .0 1 ) ]和卵巢良性肿瘤组 [( 6 4 .0 7± 7.0 2U ml) ,( 2 5.2 9± 31 .6 3)U mlP <0 .0 1 ) ];内膜异位症组CA1 2 5 明显高于良性肿瘤组 (P <0 .0 1 ) ,两组TSGF水平无差异。②卵巢恶性肿瘤组TSGF、CA1 2 5 阳性检出率( 6 3.33%、76 .6 7% )明显高于良性肿瘤组 ( 1 8.92 %、7.1 4% ,P <0 .0 1 )和内膜异位症组 ( 2 5.0 0 %、31 .2 5% ,P <0 .0 1 )。③TSGF和CA1 2 5对卵巢癌的诊断敏感率为 6 3.33%和 76 .6 7% ,而二者联合检测敏感率达 90 .0 0 %。结论 :TSGF的检测对卵巢恶性肿瘤的诊断有辅助作用 ,且能弥补CA1 2 5诊断内膜异位症的不足 ,有利于盆腔肿块的鉴别 ;TSGF和CA1 2 5联合检测能明显提高卵巢癌的诊断敏感性。 Objective:To investigate the diagnostic value of TSGF(Tumor Supplied Group of Factors) and CA 125 on malignant ovarian neoplasm.Methods:Determine the levels of serum TSGF and CA 125 in 30 women cases of ovarian cancers,37 cases of benign ovarian tumor and 16 cases of endometrioses. Compare the diagnostic sensitivity, specificity and coincident ratio of two parameters. Results:The levels of TSGF and CA 125 of malignant group[(79.62±13.58) U/ml,(251.23±272.48) U/ml]are significantly higher than these of the endometriosis group[(58.47±14.51) U/ml,(69.76±109.73) U/ml, P <0.01)]and the benign group[(64.07±7.02) U/ml,(25.29±31.63) U/ml, P <0.01)];The level of CA 125 of malignant group is significantly higher than that of the endometriosis group( P <0.01),but the level of TSGF is not significant in the 2 groups. The positive rates of TSGF and CA 125 in malignant group(63.33%,76.67%)are significantly higher than those in the benign group (18.92%,7.14%, P <0.01)and in the endometriosis group(25.00%,31.25%, P <0.01).The sensitivities of TSGF and CA 125 to malignant ovarian tumor are only 63.33 % and 76.67%,but it will be up to 90.00% with 2 parameters at the same time. Conclusions:The determination of TSGF can be an auxiliary aid in diagnosing ovarian cancers, and can also make up the defect of CA 125 using to distinguish pelvic endometriosis and ovarian cancers; The determination of TSGF together with CA 125 can obviously improve the sensitivity to ovarian cancers.
出处 《镇江医学院学报》 2001年第4期455-456,共2页 Journal of Zhenjiang Medical College
关键词 TSGF CA125 卵巢肿瘤 诊断 癌抗原 TSGF CA 125 Ovarian neoplasm Diagnosis
  • 相关文献

参考文献6

  • 1[1]Reljic M, But I. Monitoring parameters in the management of patients with tubo- ovarian complexes[J]. Int J Gynaecol Obstet,1999,64(3) :273 ~ 279.
  • 2[2]Altaras MM, Goldberg GL, Levin W, et al. What is a normal CA125 level[J]. Gynecol Oncol, 1995,56(3) :475 ~ 476.
  • 3[3]Eltabbakh GH, Belison JL, Kennedy AW, et al. Serum measurements> 65 U/ml clinical value[J]. J Reprod Med, 1997,42(10) :617 ~ 624.
  • 4[4]Hogdall CK, Mogensen O, Tabor A, et al. The role of serum tetranectin, CA125 and a combined index as tumor markers in women with pelvic tumors[J]. Gynecol Oncol, 1995,56( 1):22~ 28.
  • 5[5]Schwartz PE, Chambers JT, Taylor KJ. Early detection and screening for ovarian cancer[J]. J cell Biochem(Suppl), 1995,23,233 ~ 237.
  • 6[6]Pinto MM, Kotta S. CA125 in fine-neddle aspirates of solid tumors: comparison with cytologic diagnosis and carcinoembryonic antigen assay[J]. Diagn Cytopathlo, 1996,14(2): 121 ~ 125.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部